PACB
Pacific Biosciences of CaliforniaNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$378.93M
P/E Ratio
—
EPS
$-0.41
Beta
2.40
52W High
$2.73
52W Low
$0.85
50-Day MA
$1.43
200-Day MA
$1.67
Dividend Yield
—
Profit Margin
-80.30%
Forward P/E
—
PEG Ratio
-0.17
About Pacific Biosciences of California
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $160.03M |
| Gross Profit (TTM) | $61.33M |
| EBITDA | $-143.15M |
| Operating Margin | -102.90% |
| Return on Equity | -273.60% |
| Return on Assets | -12.00% |
| Revenue/Share (TTM) | $0.53 |
| Book Value | $0.01 |
| Price-to-Book | 158.85 |
| Price-to-Sales (TTM) | 2.37 |
| EV/Revenue | 5.02 |
| EV/EBITDA | 140.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.10% |
| Shares Outstanding | $310.60M |
| Float | $302.35M |
| % Insiders | 8.77% |
| % Institutions | 54.05% |
Historical Volatility
HV 10-Day
66.90%
HV 20-Day
89.56%
HV 30-Day
86.51%
HV 60-Day
76.97%
HV Rank
48.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.46 target)
4
Buy3
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026